Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Taiko Pharmaceutical Gains Most Since Listing on Drug-Resistant Bacteria
Bloomberg
Tuesday, September 7, 2010 - 9:44am
tags:
Taiko, antibiotics, antiseptics, Japan
Elan’s board spat hits Dublin High Court
FT.com
Tuesday, September 7, 2010 - 9:42am
tags:
Elan
CellDex Therapeutics Gets Hammered After Divorce With Pfizer, Time to Buy?
Seeking Alpha
Tuesday, September 7, 2010 - 9:41am
tags:
Pfizer, Celldex
What went wrong with Gardasil
CNN/Fortune
Tuesday, September 7, 2010 - 9:40am
tags:
Merck, vaccines, Gardasil, HPV, cervical cancer
Pressure on GSK as calls for Avandia withdrawal gather pace
Pharma Times, UK
Monday, September 6, 2010 - 10:17am
tags:
GSK, Avandia, diabetes
Aurobindo Signs Agreement to Supply Antibiotic, Heart Drugs to AstraZeneca
Bloomberg
Monday, September 6, 2010 - 10:13am
tags:
Aurobindo, AstraZeneca, antibiotics
Glaxo's Avandia Should Be Pulled From U.K. Market, BMJ Chief Editor Says
Bloomberg
Monday, September 6, 2010 - 10:11am
tags:
GSK, Avandia, diabetes, Bristol-Myers Squibb
Axial Capital Can't Get Enough of QLT
Seeking Alpha
Monday, September 6, 2010 - 10:09am
tags:
QLT
Does Bristol-Meyers Squibb Pass Buffett's Test?
Motley Fool
Monday, September 6, 2010 - 10:07am
tags:
Warren Buffett, Bristol-Myers Squibb
Arena's Lorcaserin: Weighed Down by Qnexa and Meridia
Seeking Alpha
Monday, September 6, 2010 - 10:04am
tags:
Arena Pharmaceuticals, obesity, lorcaserin, Qnexa, Meridia, Vivus
Red Signal for AstraZeneca Drug
Yahoo/Zacks.com
Monday, September 6, 2010 - 10:01am
tags:
AstraZeneca, MedImmune, RSV, motavizumab
Report into J&J product recalls looms
FT.com
Monday, September 6, 2010 - 9:59am
tags:
JNJ, recalls
Roche Plans Cutbacks on Pressure From Failures: Biotech's Latest Mishaps
Seeking Alpha
Monday, September 6, 2010 - 9:58am
tags:
Roche, layoffs, Abbott Laboratories, AstraZeneca, Pfizer, Celldex, Ranbaxy, Allergan
History Predicts Genzyme Will Sell For $80 Per Share
Minyanville
Saturday, September 4, 2010 - 1:46pm
tags:
Genzyme, M&A, Sanofi
Docs more receptive to reps at industry confabs
Fierce Pharma
Saturday, September 4, 2010 - 7:30am
tags:
physicians, drug reps, physician access
Novartis Malaria Drug May Yield First New Treatment in 30 Years
Bloomberg
Saturday, September 4, 2010 - 7:28am
tags:
Novartis, malaria
Is King Pharmaceuticals a Cash Machine?
Motley Fool
Saturday, September 4, 2010 - 7:26am
tags:
King
Family Wins Fight Linking MMR Vaccine To Epilepsy
Pharmalot
Friday, September 3, 2010 - 12:13pm
tags:
vaccines, epilepsy, MMR
A Look at Immunogen Beyond the T-DM1 Setback
Seeking Alpha
Friday, September 3, 2010 - 12:11pm
tags:
Immunogen, TDM1
BDSI shares surge on postive Onsolis meeting with FDA
Bizjournals.com
Friday, September 3, 2010 - 12:08pm
tags:
BioDelivery Sciences, Onsolis, FDA

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.